Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].
Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.
Crit Care. 2005 Oct 5;9(5):R508-15. Epub 2005 Aug 5.PMID: 16277712 [PubMed - indexed for MEDLINE]Related articlesFree article